Exploration of nucleoside analogs as potential antimicrobials against foodborne bacterial pathogens
Abstract
Background Foodborne illness remains a major health concern of human diseases worldwide. The rapid increase in antimicrobial-resistant pathogens has substantially limited available treatment options, highlighting the urgent need to discover novel antimicrobial agents. Although nucleoside analogs have been extensively developed as anticancer antimetabolites, their antimicrobial potential remains largely unexplored. Therefore, this study aimed to explore the antimicrobial activity of a nucleoside analog library against six common foodborne bacterial pathogens via in vitro screening. Results A total of 290 nucleoside analogs were screened at a single cutoff concentration of 20 µM. Among the compounds tested, zidovudine (AZT) and floxuridine (FUDR) exhibited potent antimicrobial activity. AZT demonstrated strong activity against Salmonella Typhimurium and Shigella sonnei , with MICs of 0.625 µM and 0.1562 µM, respectively. FUDR inhibited methicillin-resistant Staphylococcus aureus and Listeria monocytogenes , with MICs of 0.625 µM and 1.25 µM, respectively. Growth kinetics further confirmed the dose-dependent antimicrobial activity of both compounds. Furthermore, bacterial cytological profiling demonstrated that AZT and FUDR potentially affect DNA replication, which was further supported by the differential expression of DNA biosynthesis-related genes. Molecular docking analysis further suggested potential interactions between FUDR and thymidylate synthase in L. monocytogenes . Conclusion In vitro screening of nucleoside analogs highlights the potent antimicrobial activity of AZT and FUDR against foodborne bacterial pathogens. These findings provide insights into their efficacy, establishing a foundation for the future development and repurposing of nucleoside-based antibacterial therapeutics.